HAI
REGN icon

Hennessy Advisors Inc’s Regeneron Pharmaceuticals REGN Stock Holding History

Hennessy Advisors Inc’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,100
Closed -$2.96M – 269
2022
Q4 		$2.96M Sell
4,100
-300
-7% -$221K 0.19% 164
2022
Q3 		$3.03M Hold
4,400
– – 0.21% 146
2022
Q2 		$2.6M Sell
4,400
-100
-2% -$65K 0.16% 183
2022
Q1 		$3.14M Sell
4,500
-1,300
-22% -$822K 0.16% 192
2021
Q4 		$3.66M Sell
5,800
-200
-3% -$123K 0.21% 175
2021
Q3 		$3.63M Sell
6,000
-100
-2% -$62.1K 0.22% 157
2021
Q2 		$3.41M Buy
6,100
+100
+2% +$50.7K 0.19% 180
2021
Q1 		$2.84M Buy
+6,000
New +$2.92M 0.17% 216
2018
Q1 		– Sell
-2,010
Closed -$756K – 410
2017
Q4 		$756K Buy
+2,010
New +$814K 0.02% 298

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return